The Impact of 3′UTR Variants on Differential Expression of Candidate Cancer Susceptibility Genes

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Skeeles, Laura E ^a   Fleming, Jessica L ^a   Mahler, Kimberly L ^a   Toland, Amanda Ewart ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MICRORNA; 3' UNTRANSLATED REGION; MESSENGER RNA;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BCAP29 GENE; BINDING SITE; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DGKB GENE; ETV1 GENE; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HBP1 GENE; IFRD1 GENE; LINKAGE ANALYSIS; MOUSE; NONHUMAN; PIK3CG GENE; POLYMERASE CHAIN REACTION; PREDICTION; RNA BINDING; SITE DIRECTED MUTAGENESIS; SKIN CANCER; SKIN TUMOR SUSCEPTIBILITY 5 GENE; STRAIN DIFFERENCE; TSPAN13 GENE; TWISTNB GENE; ANIMAL; CELL LINE; CROSS BREEDING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; METABOLISM; NEOPLASM; ONCOGENE; SPECIES DIFFERENCE;

3' UNTRANSLATED REGIONS; ANIMALS; BINDING SITES; CELL LINE; CROSSES, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; MICE; MICRORNAS; MUTAGENESIS, SITE-DIRECTED; NEOPLASMS; ONCOGENES; POLYMORPHISM, GENETIC; RNA, MESSENGER; SPECIES SPECIFICITY;

EID: 84874637732     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058609     Document Type: Article

References (30)

1. Nagase H, Bryson S, Cordell H, Kemp CJ, Fee F, et al. (1995) Distinct genetic loci control development of benign and malignant skin tumors in mice. Nat Genet 10: 424-429.
2. Ewart-Toland A, Briassouli P, de Koning JP, Mao JH, Yan J, et al. (2003) Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Genet 34: 403-412.
3. Nagase H, Mao JH, Balmain A, (2003) Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice. Cancer Res 63: 4849-4853.
4. Mahler KL, Fleming JL, Dworkin AM, Gladman N, Cho H-Y, et al. (2008) Sequence divergence of Mus Spretus and Mus Musculus across a skin cancer susceptibility locus. BMC Genomics 23: 626.
5. Majewski J, Pastinen T, (2011) The study of eQTL variations by RNA-seq: from SNPs to phenotypes. Trends Genet 27: 72-79.
6. Pastinen T, (2010) Genome-wide allele-specific analysis: insights into regulatory variation. Nat Rev Genet 11: 533-538.
7. Pastinen T, Ge B, Hudson TJ, (2006) Influence of human genome polymorphism on gene expression. Hum Mol Genet 15: R9-16.
8. Emerson JJ, Li WH, (2010) The genetic basis of evolutionary change in gene expression levels. Philos Trans R Lon B Biol Sci 365: 2581-2590.
9. Knight JC, (2012) Resolving the variable genome and epigenome in human disease. J Intern Med 271: 379-391.
10. Arnold M, Ellwanger DC, Hartsperger ML, Pfeurfer A, Stumpflen V, (2012) Cis-acting polymorphisms affect complex traits through modifications of microRNA regulation pathways. PLoS One 7: e36694.
11. Ryan BM, Robels AI, Harris CC, (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10: 389-402.
12. Landi D, Gemignani F, Landi S, (2012) Role of variations within microRNA-binding sites in cancer. Mutagenesis 27: 205-210.
13. Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, et al. (2010) Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res 70: 2789-2798.
14. Gong J, Tong Y, Zhang H-M, Wang K, Hu T, et al. (2012) Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mut 33: 254-263.
15. Chin L, Ratner E, Leng S, Zhai R, Nallur S, et al. (2008) A SNP in a let-7 microRNA complementary site in the KRAS 3′UTR increases non-small cell cancer risk. Cancer Res 69: 5970-5977.
16. Ratner E, Lu L, Boeke M, Barnett R, Nallus S, et al. (2010) A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk. Cancer Res 70: 6509-6515.
17. Kim J, Bartel DP, (2009) Allelic imbalance sequencing reveals that single-nucleotide polymorphisms frequently alter microRNA-directed repression. Nat Biotechnol 27: 472-477.
18. Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R, et al. (1991) Simplified mammalian DNA isolation procedure. Nucl Acids Res 19: 4293.
19. Beta D, Wilson M, Gabow A, Marks DS, Sanders C, (2008) The microRNA. org resource: targets and expression. Nuc Acids Res 36: D149-D153.
20. Rusinov V, Baev V, Minkov IN, Tabler M, (2005) MicroInspector, a web tool for detection of miRNA binding sites in an RNA sequence. Nucleic Acids Res 33: W696-700.
21. Hiard S, Charlier C, Coppieters W, Georges M, Baurain D, (2010) Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates. Nucleic Acids Res 38: D640-651.
22. Barenboim M, Zotlick BJ, Guo Y, Weinberger DR, (2010) MicroSNiPer: a web tool for prediction of SNP effects on putative microRNA targets. Hum Mut 31: 1223-1232.
23. Kruger J, Rehmsmeier M, (2006) RNAhybrid: microRNA target prediction easy, fast, and flexible. Nucleic Acids Res 34: W451-454.
24. Bernhart SH, Flamm C, Stradler PF, Hofacher IL, (2006) Partition Functions and Base Pairing Probabilities of RNA Heterodimers Algorithims. Mol. Biol 1: 3.
25. Nagase H, Mao JH, de Koning JP, Minami T, Balmain A, (2001) Epistatic interactions between skin tumor modifier loci in interspecific (Spretus/musculus) backcross mice. CancerRes 61: 1305-1308.
26. Jackson RJ, Standart N, (2007) How do microRNAs regulate gene expression? Sci STKE 367: re1.
27. Kong YW, Cannell IG, de Moor CH, Hill K, Garside PG, et al. (2008) The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene. Proc Natl Acad Sci USA 105: 8866-8871.
28. Sotiriou S, Gibney G, Baxevanis AD, Nussbaum RL, (2009) A single nucleotide polymorphism in the 3′UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease. Neurosci Let 461: 196-201.
29. Liu X, Jiang Y, Russell JE, (2010) A potential regulatory role for mRNA secondary structures within the prothrombin 3′UTR. Thromb Res 126: 130-136.
30. Tsao D, Shabalina SA, Gauthier J, Dokholyan NV, Diatchencko L, (2011) Disruptive mRNA folding increases translational efficiency of catechol-O-methyltransferase variant. Nucleic Acids Res 39: 6201-6212.